Certain disclosures and analyses in this Form 10-Q, including information incorporated by reference, may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995 that are subject to various risks and uncertainties. Opinions, forecasts, projections, guidance, or other statements other than statements of historical fact are considered forward-looking statements and reflect only current views about future events and financial performance. Some of these forward-looking statements include statements regarding:
| • | management’s plans and objectives for future operations; |
| • | existing cash flows being adequate to fund future operational needs; |
| • | future plans related to budgets, future capital requirements, market share growth, and anticipated capital projects and obligations; |
| • | the realization of net deferred tax assets; |
| • | the ability to curtail operating expenditures; |
| • | global statutory tax rates remaining unchanged; |
| • | the impact of future market changes due to exposure to foreign currency translations; |
| • | the possibility of certain policies, procedures, and internal processes minimizing exposure to market risk; |
| • | the impact of new accounting pronouncements on financial condition, results of operations, or cash flows; |
| • | the outcome of new or existing litigation matters; |
| • | the outcome of new or existing regulatory inquiries or investigations; |
| • | other assumptions described in this report underlying such forward-looking statements. |
Although we believe that the expectations included in these forward-looking statements are reasonable, these forward-looking statements are subject to certain events, risks, assumptions, and uncertainties, including those discussed below, the “Risk Factors” section in Part I, Item 1A of our Form 10-K for the year ended December 31, 2025, and elsewhere in this Form 10-Q and the documents incorporated by reference herein. If one or more of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results and developments could materially differ from those expressed in or implied by such forward-looking statements. For example, any of the following factors could cause actual results to vary materially from our projections:
| • | overall growth or lack of growth in the nutritional supplements industry; |
| • | plans for expected future product development; |
| • | changes in manufacturing costs; |
| • | shifts in the mix of packs and products; |
| • | the future impact of any changes to global associate career and compensation plans or incentives or the regulations governing such plans and incentives; |
| • | the ability to attract and retain independent associates and preferred customers; |
| • | new regulatory changes that may affect operations, products or compensation plans and incentives; |
| • | ability of our outside suppliers and manufacturers to supply products in sufficient quantities and comply with our product safety and quality standards or applicable law; |
| • | the competitive nature of our business with respect to products and pricing; |
| • | publicity related to our products or network marketing; and |
| • | the political, social and economic climate of the countries in which we operate; and |
| • | changes in trade policy in the United States and other countries, including the imposition of tariffs and the resulting consequences, may adversely impact our business, results of operations and financial condition. |
Forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “hopes,” “potential,” and “continues” or other similar words or the negative of such terms and other comparable terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Readers are cautioned when considering these forward-looking statements to keep in mind these risks, assumptions, and uncertainties and any other cautionary statements in this report, as all of the forward-looking statements contained herein speak only as of the date of this report.
Unless stated otherwise, all financial information throughout this report and in the Condensed Consolidated Financial Statements and related Notes include Mannatech, Incorporated and all of its subsidiaries on a consolidated basis and may be referred to herein as “Mannatech,” “the Company,” “its,” “we,” “us,” “our,” or “their.”
Our products are not intended to diagnose, cure, treat, or prevent any disease, and any statements about our products contained in this report have not been evaluated by the Food and Drug Administration, also referred to herein as the “FDA.”
PART I–** FINANCIAL INFORMATION**
